DK694188A - Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel - Google Patents

Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel

Info

Publication number: DK694188A
Authority: DK; Denmark
Prior art keywords: combination; application; pharmaceutical preparation; blocking agent; calcium channel
Prior art date: 1987-12-14

Application number

DK694188A

Other languages

English (en)

Other versions

DK694188D0 (da

Inventor

Abraham Sudilovsky

Zola Phillip Horovitz

Original Assignee

Squibb & Sons Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-14

Filing date

1988-12-13

Publication date

1989-06-15

1988-12-13 Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc

1988-12-13 Publication of DK694188D0 publication Critical patent/DK694188D0/da

1989-06-15 Publication of DK694188A publication Critical patent/DK694188A/da

Links

239000005541 ACE inhibitor Substances 0.000 title 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title 1
239000000480 calcium channel blocker Substances 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Addiction (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK694188A 1987-12-14 1988-12-13 Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel DK694188A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13245787A	1987-12-14	1987-12-14
US18882788A	1988-05-02	1988-05-02

Publications (2)

Publication Number	Publication Date
DK694188D0 DK694188D0 (da)	1988-12-13
DK694188A true DK694188A (da)	1989-06-15

Family

ID=26830371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK694188A DK694188A (da)	1987-12-14	1988-12-13	Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel

Country Status (9)

Country	Link
EP (1)	EP0321221A3 (da)
JP (1)	JPH0222235A (da)
KR (1)	KR890009413A (da)
CN (1)	CN1034312A (da)
AU (1)	AU623615B2 (da)
DK (1)	DK694188A (da)
HU (1)	HU206614B (da)
IL (1)	IL88502A (da)
PT (1)	PT89208A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8702502A (nl) *	1986-11-03	1988-06-01	Sandoz Ag	Farmaceutisch preparaat voor toepassing tegen hypertensie en congestieve cardiale insufficientie.
EP0331609A3 (de) *	1988-01-27	1992-07-01	Hoechst Aktiengesellschaft	Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
US5093129A (en) *	1989-01-30	1992-03-03	E. R. Squibb & Sons, Inc.	Method for treating addiction to a drug of abuse employing an ace inhibitor
CA2007525A1 (en) *	1989-01-30	1990-07-30	Zola P. Horovitz	Method for facilating dieting employing an ace inhibitor
US5089502A (en) *	1989-06-02	1992-02-18	E. R. Squibb & Sons, Inc.	Method for preventing or treating anxiety employing a calcium channel blocker
AU5940090A (en) *	1989-08-16	1991-04-03	Cetus Oncology Corporation	Compositions for the inhibition of protein hormone formation and uses thereof
CA2021408A1 (en) *	1989-08-31	1991-03-01	Luana R. C. Moore	Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein
US6162802A (en) *	1992-03-10	2000-12-19	Papa; Joseph	Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
CA2756107A1 (en) *	2009-03-27	2010-09-30	Calpis Co., Ltd.	Composition for regulating autonomic nervous activity and method for regulating autonomic nerve

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4830853A (en) *	1986-10-20	1989-05-16	Warner-Lambert Company	Drug compositions stabilized against oxidation
US4743450A (en) *	1987-02-24	1988-05-10	Warner-Lambert Company	Stabilized compositions
CA1323833C (en) *	1987-04-28	1993-11-02	Yatindra M. Joshi	Pharmaceutical compositions in the form of beadlets and method

1988
- 1988-11-25 IL IL88502A patent/IL88502A/xx unknown
- 1988-11-30 AU AU26404/88A patent/AU623615B2/en not_active Ceased
- 1988-12-13 HU HU886412A patent/HU206614B/hu not_active IP Right Cessation
- 1988-12-13 KR KR1019880016582A patent/KR890009413A/ko not_active Withdrawn
- 1988-12-13 DK DK694188A patent/DK694188A/da not_active Application Discontinuation
- 1988-12-13 PT PT89208A patent/PT89208A/pt not_active Application Discontinuation
- 1988-12-14 JP JP63316098A patent/JPH0222235A/ja active Pending
- 1988-12-14 CN CN88108574A patent/CN1034312A/zh active Pending
- 1988-12-14 EP EP19880311842 patent/EP0321221A3/en not_active Ceased

Also Published As

Publication number	Publication date
IL88502A (en)	1993-04-04
HUT48817A (en)	1989-07-28
KR890009413A (ko)	1989-08-01
PT89208A (pt)	1989-12-29
IL88502A0 (en)	1989-06-30
EP0321221A2 (en)	1989-06-21
HU206614B (en)	1992-12-28
AU623615B2 (en)	1992-05-21
JPH0222235A (ja)	1990-01-25
DK694188D0 (da)	1988-12-13
CN1034312A (zh)	1989-08-02
AU2640488A (en)	1989-06-15
EP0321221A3 (en)	1991-04-03

Similar Documents

Publication	Publication Date	Title
FI895681A0 (fi)	1989-11-28	Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DK0450141T3 (da)	1995-07-24	Bærermateriale til administrering af lægemidler
EE9700241A (et)	1998-04-15	Farmatseutiline kompositsioon transdermaalseks manustamiseks
DE3778106D1 (de)	1992-05-14	Dosierungsform mit verzoegernder freisetzung.
NO891893D0 (no)	1989-05-09	Sementblanding med to faser.
IT8323205A0 (it)	1983-10-07	Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ES2042776T3 (es)	1993-12-16	Un procedimiento para la preparacion de una composicion farmaceutica.
DE69725860D1 (de)	2003-12-04	PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
DK694188D0 (da)	1988-12-13	Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel
FI902673A7 (fi)	1990-05-29	Anti-inflammatoorisia ja analgeettisia yhdisteitä, niitä sisältäviä se oksia ja menetelmiä niiden valmistamiseksi sekä niiden käyttö
DK665489D0 (da)	1989-12-22	Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser
DK23790A (da)	1990-07-31	Doseringsform til administrering af en calciumantagonist
FI891865L (fi)	1989-10-21	Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
ZA898201B (en)	1991-03-27	Gestodene-containing agent for transdermal administration
DK226488D0 (da)	1988-04-26	Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
KR890701124A (ko)	1989-12-19	피브린 침착 또는 유착을 방지하기 위한 방법 및 치료 조성물
DK586188A (da)	1989-04-24	Kondenserede diazepinoner, fremgangsmaade til deres fremstilling og laegemidler med indhold af saadanne forbindelser
DK524489D0 (da)	1989-10-23	Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
BR9809478A (pt)	2000-06-20	Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo
DK291189A (da)	1989-12-16	Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne
ATE71535T1 (de)	1992-02-15	Pharmazeutische zubereitungen.
DK524889D0 (da)	1989-10-23	Anvendelse af en ace-inhibitor, evt. i kombination med et thrombolytisk middel, til fremstilling af et farmaceutisk praeparat til forbedring af post-ischaemisk myocardial dysfunktion
AR240017A1 (es)	1990-01-31	Procedimiento de preparacion de una composicion farmaceutica para absorcion percutanea.
FI952018A0 (fi)	1995-04-27	BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
ES553186A0 (es)	1987-10-16	Mejoras introducidas en el objeto de la patente principal por un procedimiento para la preparacion de derivados de urea.

Legal Events

Date	Code	Title	Description
1994-08-22	AHB	Application shelved due to non-payment